• <tr id="yyy80"></tr>
  • <sup id="yyy80"></sup>
  • <tfoot id="yyy80"><noscript id="yyy80"></noscript></tfoot>
  • 99热精品在线国产_美女午夜性视频免费_国产精品国产高清国产av_av欧美777_自拍偷自拍亚洲精品老妇_亚洲熟女精品中文字幕_www日本黄色视频网_国产精品野战在线观看 ?

    Mucosal-associated invariant T cells in hepatitis B virus-related liver failure

    2020-09-23 10:05:32HongXueHanLiLinLingJuXuDongHanTiaoChunChengXiLuoLinChenJianGuoShaoYongJunSheZhaoLianBian
    World Journal of Gastroenterology 2020年31期

    Hong Xue, Han Li, Lin-Ling Ju, Xu-Dong Han, Tiao-Chun Cheng, Xi Luo, Lin Chen, Jian-Guo Shao, Yong-Jun She, Zhao-Lian Bian

    Abstract

    Key words: Mucosal-associated invariant T cells; Chronic hepatitis B; Liver failure; Prognosis; Hepatitis B virus

    INTRODUCTION

    Liver failure is a life-threatening clinical syndrome caused by multiple factors, leading to severe impairment or decompensation of synthesis, detoxification, metabolism and biotransformation, mainly presenting a group of clinical manifestations such as jaundice, coagulopathy, hepatorenal syndrome, hepatic encephalopathy and ascites[1]. Liver failure is a devastating disease with high morbidity and mortality. In China, the main cause of liver failure is hepatitis B virus (HBV) infection[2]. It develops rapidly and has extremely poor prognosis[3], so judging the severity and predicting the prognosis of liver failure are important.

    Although there are various indicators or scoring systems for assessing the severity and prognosis in patients with liver failure, such as alanine aminotransferase, aspartate transaminase, prothrombin activity (PTA), model for end-stage liver disease (MELD) score and MELD-sodium (MELD-Na) score, these conventional scoring systems do not include extrahepatic organ failure and systemic inflammation, which limits their prognostic accuracy in liver failure. Because of the absence of gold standard markers for prognosis of liver failure[4], it is important to find additional reliable markers for predicting prognosis, enabling patients with poor prognosis to receive liver transplantation earlier to improve survival.

    Mucosal-associated invariant T (MAIT) cells, the most abundant T cell subset that responds to bacteria in humans, are characterized by the invariant T-cell receptor (TCR) chain, Vα7.2-Jα33, and show high expression of the natural killer cell marker CD161. MAIT cells are found throughout the body, especially in human blood and liver. MAIT cells mediate protective immunity against infection and are increasingly being recognized for their importance in microbial immunity. As one of the largest T cell populations in the human liver, MAIT cells act as a “firewall” and play an important role in the front line of defense in the liver. MAIT cells are involved in the development of various liver diseases[5]. They can be activated in an antigen- and cytokine-dependent manner in chronic inflammatory liver disease[6]. Recent studies have reported that MAIT cells in blood and liver in patients with chronic liver inflammatory disease, including alcoholic or nonalcoholic fatty liver disease, cirrhosis, autoimmune liver disease and chronic hepatitis C and D[7-9]are decreased dramatically, but the phenotype of MAIT cells is more activated or shows functional impairment in different types of liver disease. However, circulating MAIT cells are not reversed after direct-acting-antiviral-mediated clearance of hepatitis C virus (HCV)[10]. Further studies explored the mechanism of MAIT cell involvement in liver inflammatory disease, including promoting liver inflammation and fibrosis dependent on monocytederived macrophages, maintaining intestinal mucosal permeability[11]and reacting with biliary epithelium and liver B cells[12]. From previous studies, tumor-infiltrating MAIT cells are a prognostic factor for hepatocellular carcinoma[13]and colorectal cancer[14]. Circulating MAIT cells are also a biomarker for response to standard treatment in primary biliary cholangitis[15]and immune thrombocytopenia[16]and prognosis in cervical cancer[17].

    There are various reports about the frequency of circulating MAIT cells in patients with HBV infection. Yong and colleagues found that frequency of MAIT cells was decreased, presenting dysfunction in chronic hepatitis B (CHB) infection[18]. Boeijen et al[12]reported that MAIT cells were more activated and could be reversed by antiviral therapy, but the frequency of circulating MAIT cells was not decreased in CHB infection. In acute liver failure, it was reported that hepatic MAIT cells accumulated in the parenchyma, but the circulating MAIT cells were not detected and the etiology of liver failure was not revealed[19]. In China, the hepatitis B infection is the major cause of liver failure and T-cell-mediated immune injury plays a critical role in the pathogenesis of HBV-related liver failure. In this paper, we evaluated the change of circulating MAIT cells and its prognostic value in patients with HBV-related liver failure and explored the possible mechanism.

    MATERIALS AND METHODS

    Patient data

    A total of 173 participants were enrolled, including 40 healthy controls, 48 CHB patients and 85 liver failure patients. We excluded 30 non-HBV related liver failure patients and enrolled 55 HBV related liver failure patients (Figure 1). Liver failure was diagnosed and treated according to the Guidelines in China[20]. CHB patients (n= 48) were diagnosed according to the American Association for the Study of Liver Disease 2018 guidelines for hepatitis B[21]. HBV-related liver failure (n= 55) was defined as liver failure accompanied with HBV activity, which was considered as HBV-DNA positive, and without other causes of liver failure. None of the patients in the CHB and HBVrelated liver failure groups received any antiviral therapy before the study, or antiviral drugs were discontinued for > 6 mo before the study. The research process is shown in a flow chart (Figure 1), and the demographic and clinical characteristics of the participants are presented in Table 1. This study was approved by the Ethical Committee of Nantong Third People’s Hospital, Nantong University, and patients gave signed informed consent.

    Peripheral blood mononuclear cells isolation

    Peripheral blood mononuclear cells (PBMCs) were isolated by density centrifugation with GE Healthcare Ficoll-Paque PLUS Media (Thermo Scientific, Rosemont, IL, United States) as our previous study described[22]. Five milliliters of peripheral blood was centrifuged for 10 min at 300 ×gat 20 °C. The buffy coat interphase layer wascollected and then placed in a new 1.5-mL centrifuge tube. The buffy coat was mixed with an equal volume of phosphate-buffered saline. Then, 3 mL Ficoll was placed in a 15-mL centrifuge tube; the diluted buffy coat was layered on top of it; and the tube was centrifuged for 30 min at 400 ×gwith no break at room temperature. The PBMC layer was transferred and washed by phosphate-buffered saline. PBMCs were collected after centrifugation for 10 min at 300 ×gand stored in fetal bovine serum (Cell Sciences, Canton, MA, United States) with 10% dimethyl sulfoxide (Beyotime Biotechnology, Shanghai, China) in liquid nitrogen for further analysis.

    Table 1 Characteristics of healthy controls and chronic hepatitis B and hepatitis B virus-related liver failure patients

    Flow cytometry

    PBMCs were stained with combinations of the following antibodies: anti-TCRVα7.2-phycoerythrin (PE; BD Biosciences, Franklin Lakes, NJ, United States), anti-CD161-allophycocyanin (APC; BD Biosciences) and anti-CD3-fluorescein isothiocyanate (FITC; BD Biosciences). Flow cytometry was performed using FACS Calibur (BD Biosciences). Data were analyzed using FlowJo software (Tree Star, San Carlos, CA, United States).

    Plasma cytokine detection

    Interleukin (IL)-7, IL-12p70, IL-18 and interferon (IFN)-α were measured using the Human Magnetic Luminex Assay Kit (R&D Systems, Minneapolis, MN, United States) in human plasma samples. The results were read and analyzed on Luminex MAGPIX Instrument System (Luminex, Austin, TX, United States).

    Statistical analysis

    Figure 1 Flow chart for patient enrollment and analysis. Diagram showing the general process from enrolling patients to the final analysis. CHB: Chronic hepatitis B; HBV: Hepatitis B virus.

    All data are presented as mean ± standard deviation. Analysis in patients before and after therapy was done by pairedttest. One-way analysis of variance was used to analyze differences between more than two groups. The comparison of two groups was carried out byttest. Statistical evaluations were conducted with GraphPad Prism software version 8.0 (La Jolla, CA, United States), andP< 0.05 was considered statistically significant.

    RESULTS

    Characteristics of healthy controls and patients with CHB and HBV-related liver failure

    The detailed clinical characteristics of the participants, including healthy controls (HCs) (n= 40), patients with CHB (n= 48) and patients with HBV-related liver failure (n= 55), are presented in Table 1. There were no differences in age and gender between patients with CHB, patients with HBV-related liver failure and HCs. The levels of alanine aminotransferase (HBV-related liver failurevsHC: 549.60 ± 686.13vs16.55 ± 5.43,P< 0.0001; HBV-related liver failurevsCHB: 549.60 ± 686.13vs327.52 ± 312.57,P< 0.05), aspartate transaminase (HBV-related liver failurevsHC: 487.55 ± 571.49vs22.95 ± 5.70,P< 0.0001; HBV-related liver failurevsCHB: 487.55 ± 571.49vs176.58 ± 208.19,P< 0.001) and total bilirubin (HBV-related liver failurevsHC: 302.52 ± 144.84vs12.48 ± 3.23,P< 0.0001; HBV-related liver failurevsCHB: 302.52 ± 144.84vs25.65 ± 43.43,P< 0.0001) were dramatically increased in HBV-related liver failure group compared to HCs and CHB group. The levels of albumin (HBV-related liver failurevsHC: 31.01 ± 4.06vs42.98 ± 2.32,P< 0.0001; HBV-related liver failurevsCHB: 31.01 ± 4.06vs42.36 ± 3.99,P< 0.0001) and blood platelets (HBV-related liver failurevsHC: 97.96 ± 52.06vs194.68 ± 41.53,P< 0.0001; HBV-related liver failurevsCHB: 97.96 ± 52.06vs157.52 ± 67.53,P< 0.0001) were significantly decreased in HBV-related liver failure group compared to HCs and CHB group (Table 1).

    Circulating MAIT cells were dramatically decreased in HBV-related liver failure

    Circulating MAIT cells were defined as CD3+CD161+TCR Vα7.2+. The strategy for flow cytometry of MAIT cells is illustrated in Figure 2A. We counted the percentage of circulating MAIT cells in CD3+T cells and the number of circulating MAIT cells in 106PBMCs in patients with HBV-related liver failure, patients with CHB and HCs. The percentage and number of circulating MAIT cells in HBV-related liver failure patients (percentage: 2.00 ± 1.22vs5.19 ± 1.27%,P< 0.0001; number: 5.47 ± 4.93vs84.43 ± 19.59,P< 0.0001) and CHB (percentage: 3.59 ± 0.87vs5.19 ± 1.27%,P< 0.0001; number: 48.26 ± 15.45vs84.43 ± 19.59,P< 0.0001) were significantly lower than in HCs. Circulating MAIT cells exhibited a significant decrease in HBV-related liver failure patients compared with CHB patients (percentage: 2.00 ± 1.22vs3.59 ± 0.87%,P< 0.0001; number: 5.47 ± 4.93vs48.26 ± 15.45,P< 0.0001) (Figure 2B and C).

    Quantity of circulating MAIT cells was associated with severity in HBV-related liver failure patients

    Patients with HBV-related liver failure were divided into two groups according to the level of PTA: Early stage (n= 28) and middle/late stage (n= 27). The percentage and number of circulating MAIT cells were analyzed. A significant reduction in percentage (Figure 3A) and number (Figure 3B) of MAIT cells was found in patients with middle/late-stage disease compared with early stage. We analyzed the correlation between MAIT cells and parameters in Table 1, and data showed that PTA was not associated with percentage of MAIT cells (Figure 3C) but correlated with MAIT cell counts (P= 0.0321) (Figure 3D). Other parameters were not associated with the percentage or number of circulating MAIT cells in HBV-related liver failure (data not shown).

    Partial recovery of circulating MAIT cells in surviving HBV-related liver failure patients

    We collected PBMCs from 18 patients before and after therapy, including 13 surviving patients and five patients who died or received liver transplantation. The indicated time for post-therapy was defined as the endpoint of conservative treatment in patients who were cured, died or received liver transplantation. We analyzed the variation in percentage and number of circulating MAIT cells in these patients. In the survival group (n= 13), circulating MAIT cells were partially recovered after disease improvement not only in percentage (4.01 ± 1.21vs2.04 ± 0.95%,P< 0.0001) (Figure 4A), but also in cell count (17.24 ± 8.56vs7.41 ± 4.99,P< 0.0001) (Figure 4B) and they were still lower than in HCs, especially MAIT cell count (Figure 4A and B). However, the level of circulating MAIT cells showed no difference in before and after conservative treatment among those who died and received liver transplantation (n= 5) (Figure 4C and D).

    Lower circulating MAIT cells indicated poor prognosis in HBV-related liver failure

    Based on the outcome, we divided the HBV-related liver failure patients into the survival group (n= 32) and died/liver transplanted group (n= 23). Comparison of MAIT cells between them showed that the proportion (2.29 ± 1.01vs1.58 ± 1.38%,P< 0.05) (Figure 5A) and number of circulating MAIT cells (7.30 ± 5.70vs2.94 ± 1.47,P< 0.001) (Figure 5B) were significantly higher in the survival group than the died/LT group. We followed up the 55 HBV-related liver failure patients for 2-90 d, then the patients were divided into two groups, low expression (n= 27) and high expression (n= 28) of MAIT cells based on median proportion or cell counts of circulating MAIT cells. The Kaplan–Meier curve showed that lower expression of circulating MAIT cells (both percentage and cell count) predicted poor overall survival in HBV-related liver failure patients (P< 0.01) (Figure 5C and D). We compared the prognostic value of MELD score with MAIT cells (proportion and counts) and showed using receiver operating characteristic curve data that the proportion of MAIT cells can better predict the prognosis of HBV-related liver failure patients than MELD score and MAIT cell counts (Figure 6).

    Figure 2 Circulating mucosal-associated invariant T cells were dramatically decreased in hepatitis B virus-related liver failure. A: The strategy for flow cytometry of mucosal-associated invariant T (MAIT) cells; B: The percentage of circulating MAIT cells in healthy controls (HC, n = 40), chronic hepatitis B (CHB, n = 48) patients and hepatitis B virus (HBV)-related liver failure (LF) patients (n = 55); C: Circulating MAIT cell count in 106 peripheral blood mononuclear cells in HCs and CHB and HBV-related liver failure patients. bP < 0.0001.

    Plasma levels of IL-12 and IL-18 were increased in patients with HBV-related liver failure

    It is well recognized that MAIT cells can be activated and exhausted by inflammatory cytokines, including IL-12, IL-18, IL-7 and IFN-α[23,24]. To explore the possible mechanism of decreased circulating MAIT cells in HBV-related liver failure, we detected these inflammatory cytokines in the plasma of HBV-related liver failure patients (n= 46) and HCs (n= 40). The level of IL-12 (20.26 ± 5.42 pg/mLvs17.76 ± 2.79 pg/mL,P= 0.01) and IL-18 (1470.05 ± 1525.38 pg/mLvs362.99 ± 109.64 pg/mL,P< 0.0001) were increased in HBV-related liver failure patients compared to HCs (Figure 7A and B). However, there was no difference in IL-7 and IFN-α between the two groups (Figure 7C and D). These data indicated that IL-12 and IL-18 contributed to the depletion of circulating MAIT cells in HBV-related liver failure patients.

    Figure 3 Quantity of circulating mucosal-associated invariant T cells was associated with severity of hepatitis B virus-related liver failure. A, B: The percentage (A) and number (B) of circulating mucosal-associated invariant T (MAIT) cells in early- (n = 28) and middle/late-stage (n = 27) hepatitis B virus (HBV)-related liver failure; C, D: Correlation between prothrombin activity (PTA) and percentage (C) or number (D) of circulating MAIT cells in patients with HBV-related liver failure. aP < 0.05, bP < 0.01. PBMC: Peripheral blood mononuclear cell. NS: No significance.

    DISCUSSION

    In previous studies, MAIT cells were reported in multiple tissues, including liver, lung, pancreas, female genital mucosa, spleen and lymph nodes[25]. They represent about 6% of all CD3+T cells in human blood and up to 20% in the lungs. More importantly, MAIT cells account for up to 40% of T cells in the liver[26], which indicates that they play a critical role in liver disease. MAIT cells are involved in many types of immune disorders, including viral[27]and bacterial[28]infections. From further study, we know that MAIT cells recognize microbial metabolites and rapidly respond to pathogens, release cytokines, lyse target cells and promote inflammatory response, including in infectious and noninfectious inflammatory diseases, by secreting Th1 and Th17 cytokines. MAIT cells also play a critical role in liver diseases by promoting hepatitis and fibrosis, maintaining intestinal permeability and responding to biliary epithelium cells and liver B cells. MAIT cells were reported to be activated in patients with cirrhosis and displayed a proinflammatory profile. The profibrogenic functions of MAIT cells suggested that targeting MAIT cells may constitute an attractive antifibrogenic strategy during chronic liver injury. In addition, MAIT cells have antibacterial potency and play a key role as biliary firewall protecting the epithelial lining from translocated bacteria. In patients with alcoholic liver disease, the antibacterial potency of MAIT cells are impaired as a consequence of contact with microbial products and microbiota, which results in susceptibility to infection.

    Figure 4 Partial recovery of circulating mucosal-associated invariant T cells in survived hepatitis B virus-related liver failure patients. A, B: The percentage (A) and count (B) of circulating mucosal-associated invariant T (MAIT) cells before and after treatment of surviving patients (n = 13) with hepatitis B virus (HBV)-related liver failure, and in healthy controls (HC) (n = 40); C, D: The percentage (C) and number (D) of MAIT cells in patients (n = 5) who died or underwent liver transplantation in HBV-related liver failure before and after conservative treatment. bP < 0.01, dP < 0.0001. NS: No significance; PBMC: Peripheral blood mononuclear cell.

    Figure 5 Lower count of circulating mucosal-associated invariant T cells indicated poor prognosis in hepatitis B virus-related liver failure. A, B: The proportion (A) and number (B) of circulating mucosal-associated invariant T (MAIT) cells in surviving (n = 32) and deceased/liver transplanted (LT) (n = 23) patients with hepatitis B virus (HBV)-related liver failure; C, D: The Kaplan–Meier curve of HBV-related liver failure patients with low (n = 27) and high (n = 28) expression of MAIT cells in percentage (C) and count (D). aP < 0.05, cP < 0.001. PBMC: Peripheral blood mononuclear cell.

    The liver is an important immune organ in humans, with unique immune cells. MAIT cells are located around the bile ducts in the portal tracts and can exert antibacterial and antiviral effects. Hegdeet al[7]found that circulating MAIT cells were reduced in patients with alcoholic or nonalcoholic fatty liver disease-related cirrhosis. Yonget al[29]demonstrated that peripheral MAIT cells were significantly decreased in chronic HBV-infected patients. In line with the results above, we discovered that circulating MAIT cells were significantly reduced in patients with CHB. Additionally, we found that circulating MAIT cells were dramatically decreased in HBV-related liver failure compared with CHB. These findings may indicate that HBV-related liver failure may represent a more advanced and aggressive state of inflammatory cascade that may be incriminated in the more depressive effect on the status of circulating MAIT cells. However, Boeijenet al[12]suggested that MAIT cells were not depleted in chronic HBV-infected patients but more activated. The reason for this difference may include the number of patients and the different stages of the disease. In recent research, Niehauset al[30]demonstrated enrichment of MAIT cells in the peritoneal cavity, but circulating MAIT cells were dramatically decreased in patients with cirrhosis. Also, they reported that MAIT cells in ascites were almost intact and highly activated. This was because ascites in patients with decompensated cirrhosis represents a special immune environment, which is different from peripheral blood, resulting in different observed cell phenotypes and functions.

    Immune responses play a crucial role in the pathogenesis of liver failure, and T-cellmediated immune responses play a critical role in the pathogenesis of HBV-related acute-on-chronic liver failure (ACLF). The enrichment of MAIT cells in the liver and its anatomical location close to the biliary tract suggest that MAIT cells play an important role in liver immune defense and possibly HBV-related liver failure. A recent study[31]suggested that T-cell-mediated immune response plays a vital role in acute HBV infection and the pathogenesis of HBV-related ACLF, which suggests that T-cell responses play a crucial role in virus control and immune-mediated liver damage. Another recent study[32]showed that chronic HBV and HCV infections always lead to T-cell depletion or dysfunction, which results in immune tolerance and viral persistence. The pathogenesis of ACLF is also a dysfunctional immune response caused by systemic inflammation and increased immune cell paralysis.

    Figure 6 The prognostic value of model for end-stage liver disease score, mucosal-associated invariant T cell counts and percentage of mucosal-associated invariant T cells in patients with hepatitis B virus-related liver failure. The receiver characteristic operator curve of model for end-stage liver disease (MELD) score and mucosal-associated invariant T (MALT) cells counts and percentage (%). AUC: Area under the curve.

    B?ttcheret al[9]showed that MAIT cells were decreased in peripheral blood and liver tissue in autoimmune immune liver disease and found that intrahepatic MAIT cells tended to decrease with increasing fibrosis stage. They considered that the decrease was related to long-term exposure to cytokines and bacterial antigens, resulting in cell exhaustion. Together with their findings, our data showed a more significant decrease of circulating MAIT cells when the patients’ condition worsened. During the middle/late stage of liver failure, perhaps due to the long-term chronic course, circulating MAIT cells are increasingly depleted and the body mounts a dysfunctional immune response and enters an immunosuppressive state, resulting in viral persistence and aggravated conditions. Given that patients with end-stage chronic liver disease in most cases have at least some degree of malnutrition and decreased protein synthesis, maybe MAIT cells’ decrease is also associated with malnutrition, decreased protein synthesis and the reduction of lymphocytes.

    Previous research has suggested that successful antiviral therapy does not restore the frequency of circulating MAIT cells, such as in patients with CHB or HCV or human immunodeficiency virus infection. Bolte and Rehermann[6]once mentioned that HCV infection leaves a lasting imprint on the MAIT cell population. We discovered that after treatment, the frequency and number of circulating MAIT cells partially recovered when HBV-related liver failure improved. We believe that in different immune environments of diseases, the circulating MAIT cells may undergo different immune processes (including immune exhaustion and chronic immune activation), resulting in different function and behavior of MAIT cells in the systemic circulation. This was an important discovery, and it is worthy of further study to explore the mechanism in patients with HBV-related liver failure.

    Figure 7 Plasma levels of interleukin-12 and interleukin-18 were increased in patients with hepatitis B virus-related liver failure. A-D: Plasma level of interleukin (IL)-12p70 (A), IL-18 (B), IL-7 (C) and interferon-α (D) in healthy controls (HC) (n = 40) and patients with hepatitis B virus (HBV)-related liver failure (n = 46). aP < 0.05; dP < 0.0001. NS: No significance.

    Shenet al[31]have mentioned the lack of predictive prognostic biomarkers for hepatitis B virus-related acute-on-chronic liver failure (HBV-ACLF). Currently, the predictive scoring systems (including MELD and MELD-Na) for assessing the prognosis of patients with liver failure have defects, such as too complex, low sensitivity and limited application value. The prognosis of liver failure patients is poor. To find an objective, accurate and convenient prognostic marker for clinical application is still urgently needed. Given that the immune response plays a crucial role in the pathogenesis of liver failure, some immune-related prognostic markers appear, such as tumor necrosis factor-α-induced protein-8 like-2[33]. The latter is reported to have a potential role in predicting prognosis in patients with HBV-ACLF by negative regulation of cell-mediated immunity. Also, there were reports that peripheral myeloid-derived suppressor cells[34]and CD8 T cells acted as biomarkers for prognosis in HBV-ACLF. Our data indicate that circulating MAIT cells are an important marker for predicting the prognosis of HBV-related liver failure by showing obvious reduction of MAIT cells in deceased compared to surviving patients and a higher survival rate accompanied by higher expression of MAIT cells. It may be that depletion of MAIT cells leads to immunosuppression, increasing the risk of opportunistic infections, with severe consequences. Therefore, MAIT cells are vital for assessing the prognosis of patients with HBV-related liver failure, and early assessment can help physicians determine earlier which patients should receive liver transplantation and thus improve their prognosis.

    Previous studies have shown that the exhaustion of blood MAIT cells may be caused by inflammatory cytokines, including IL-12, IL-18, IFN-α and IL-7. To explore further the possible mechanism of MAIT cell reduction in HBV-related liver failure, we quantified the plasma level of IL-7, IL-12p70, IL-18 and IFN-α. The results showed that plasma levels of IL-12 and IL-18 were increased obviously in HBV-related liver failure. Zhanget al[35]concluded that, in parallel to the reduction of MAIT cells, the increase in IL-12 and IL-18 may contribute to MAIT cell activation, loss or death. We inferred that depletion of circulating MAIT cells might be caused by stimulation by IL-12 and IL-18 in HBV-related liver failure.

    In conclusion, circulating MAIT cells are decreased in HBV-related liver failure and associated with disease severity. Most importantly, circulating MAIT cells have a potential role in predicting prognosis in HBV-related liver failure patients. The mechanism of MAIT cell depletion needs to be further studied.

    ARTICLE HIGHLIGHTS

    Research background

    Immune responses play a crucial role in the pathogenesis of liver failure. Mucosalassociated invariant T (MAIT) cells are a novel population of innate-like lymphocytes involved in inflammatory liver disease, and their potential role in liver failure remains unclear.

    Research motivation

    To determine the role of circulating MAIT cells in patients with hepatitis B virus (HBV)-related liver failure and better understand the pathophysiological mechanism of liver failure, which is helpful for clinical decision-making.

    Research objectives

    This study aimed to explore the relationship between the alteration of circulating MAIT cells and prognosis of HBV-related liver failure.

    Research methods

    Fifty-five patients with HBV-related liver failure were enrolled to assess the effect of circulating MAIT cells. Peripheral blood mononuclear cells were isolated and the expression of circulating MAIT cells was detected by flow cytometry.

    Research results

    The level of circulating MAIT cells was reduced significantly in HBV-related liver failure patients. There was also a more significant reduction of MAIT cells in patients with HBV-related liver failure compared with chronic hepatitis B patients. The alteration of circulating MAIT cells is associated with the severity and prognosis of HBV-related liver failure.

    Research conclusions

    We conclude that the circulating MAIT cells may be an important prognostic marker for HBV-related liver failure, and the lower expression of circulating MAIT cells may indicate a poor prognosis.

    Research perspectives

    The circulating MAIT cells are vital for assessing the severity and prognosis of patients with HBV-related liver failure, and the mechanism of MAIT cell depletion needs to be further studied.

    ACKNOWLEDGEMENTS

    The authors would like to thank Nantong Third People’s Hospital Affiliated to Nantong University for their technical support.

    亚洲专区字幕在线| 91成人精品电影| 国产欧美日韩一区二区三| 午夜福利免费观看在线| 亚洲一卡2卡3卡4卡5卡精品中文| av天堂久久9| 国产精品久久久久成人av| 天天躁夜夜躁狠狠躁躁| 国产精品九九99| 久久精品成人免费网站| 国产日韩一区二区三区精品不卡| 国产精品国产高清国产av | 亚洲 国产 在线| 99精品欧美一区二区三区四区| 老鸭窝网址在线观看| 成人国产av品久久久| 国产在线观看jvid| 99国产精品一区二区蜜桃av | av电影中文网址| 久久人人97超碰香蕉20202| www.999成人在线观看| 久久久久久久久久久久大奶| www.精华液| 成人永久免费在线观看视频 | 国产激情久久老熟女| 欧美 亚洲 国产 日韩一| 女同久久另类99精品国产91| 久久久欧美国产精品| 久久亚洲真实| 久久ye,这里只有精品| 9热在线视频观看99| 国产精品久久久av美女十八| 欧美精品一区二区大全| 黑人猛操日本美女一级片| 色婷婷久久久亚洲欧美| 欧美黑人精品巨大| 欧美亚洲 丝袜 人妻 在线| 男女高潮啪啪啪动态图| 一边摸一边抽搐一进一出视频| 国产精品久久久av美女十八| 69av精品久久久久久 | kizo精华| 国产色视频综合| 天堂8中文在线网| 精品国产亚洲在线| 大香蕉久久网| 日本vs欧美在线观看视频| 午夜福利视频精品| 精品亚洲成a人片在线观看| 露出奶头的视频| 久久这里只有精品19| 久久99热这里只频精品6学生| 在线观看www视频免费| 国产91精品成人一区二区三区 | 亚洲 国产 在线| 视频区欧美日本亚洲| 精品国产乱码久久久久久小说| 精品国内亚洲2022精品成人 | av天堂在线播放| 人人妻人人澡人人爽人人夜夜| 无人区码免费观看不卡 | 国产av精品麻豆| 操出白浆在线播放| 国产成人精品久久二区二区免费| 免费黄频网站在线观看国产| 满18在线观看网站| 国产人伦9x9x在线观看| 少妇粗大呻吟视频| 成人亚洲精品一区在线观看| 成人国产av品久久久| 亚洲人成77777在线视频| 黄色片一级片一级黄色片| 久久久精品94久久精品| 丰满饥渴人妻一区二区三| 考比视频在线观看| 日本av免费视频播放| 精品第一国产精品| 日韩免费av在线播放| 亚洲av日韩精品久久久久久密| 99精品久久久久人妻精品| 成人18禁高潮啪啪吃奶动态图| 精品福利观看| 热99久久久久精品小说推荐| 欧美成狂野欧美在线观看| 淫妇啪啪啪对白视频| 超碰97精品在线观看| 国产在线视频一区二区| 汤姆久久久久久久影院中文字幕| 亚洲欧美日韩高清在线视频 | 欧美黄色淫秽网站| 水蜜桃什么品种好| 亚洲av美国av| 三级毛片av免费| 亚洲午夜理论影院| 亚洲第一av免费看| 丝袜人妻中文字幕| 热re99久久国产66热| 大型黄色视频在线免费观看| 91av网站免费观看| 在线播放国产精品三级| 激情视频va一区二区三区| 精品人妻熟女毛片av久久网站| 男人操女人黄网站| 久久精品国产综合久久久| 欧美精品高潮呻吟av久久| 51午夜福利影视在线观看| 老司机午夜福利在线观看视频 | 捣出白浆h1v1| 午夜老司机福利片| 国产在视频线精品| 欧美变态另类bdsm刘玥| 国产色视频综合| 中文字幕最新亚洲高清| 午夜视频精品福利| 亚洲av日韩精品久久久久久密| 夜夜夜夜夜久久久久| 热99国产精品久久久久久7| 日韩 欧美 亚洲 中文字幕| 亚洲国产欧美一区二区综合| xxxhd国产人妻xxx| 精品人妻1区二区| 日本a在线网址| 免费av中文字幕在线| 欧美成人午夜精品| 一个人免费在线观看的高清视频| 法律面前人人平等表现在哪些方面| 中文亚洲av片在线观看爽 | 久9热在线精品视频| 国产免费视频播放在线视频| 波多野结衣av一区二区av| av网站免费在线观看视频| 久久午夜综合久久蜜桃| 日本五十路高清| 亚洲av日韩在线播放| 国产精品 欧美亚洲| 国产亚洲一区二区精品| 久久国产精品大桥未久av| 亚洲国产欧美在线一区| 免费在线观看影片大全网站| 亚洲七黄色美女视频| 黑人猛操日本美女一级片| 国产精品久久久久久精品古装| 91成年电影在线观看| 可以免费在线观看a视频的电影网站| 下体分泌物呈黄色| 亚洲精品国产精品久久久不卡| 国产极品粉嫩免费观看在线| 日本av手机在线免费观看| 激情在线观看视频在线高清 | 99久久人妻综合| kizo精华| 狠狠婷婷综合久久久久久88av| 最近最新免费中文字幕在线| 女人精品久久久久毛片| 久久人人爽av亚洲精品天堂| 国产精品99久久99久久久不卡| 天天躁狠狠躁夜夜躁狠狠躁| 性高湖久久久久久久久免费观看| 欧美乱妇无乱码| www.熟女人妻精品国产| www日本在线高清视频| 99久久人妻综合| 女人久久www免费人成看片| 国产精品成人在线| 国产精品一区二区在线不卡| 9热在线视频观看99| 国产又爽黄色视频| 免费观看人在逋| 在线av久久热| 国产一区二区三区视频了| 极品教师在线免费播放| 色视频在线一区二区三区| 免费看a级黄色片| 国产精品 国内视频| 国产精品电影一区二区三区 | 极品教师在线免费播放| 人人澡人人妻人| videos熟女内射| 中国美女看黄片| 美女福利国产在线| 99re在线观看精品视频| 精品国产一区二区久久| 水蜜桃什么品种好| 国产有黄有色有爽视频| 久久国产精品人妻蜜桃| 国产精品久久久av美女十八| 青草久久国产| 欧美人与性动交α欧美软件| 日韩三级视频一区二区三区| 高清在线国产一区| 亚洲欧美色中文字幕在线| 亚洲五月婷婷丁香| 搡老熟女国产l中国老女人| 国产av一区二区精品久久| 欧美人与性动交α欧美精品济南到| 香蕉久久夜色| 免费在线观看完整版高清| e午夜精品久久久久久久| 国产精品免费视频内射| 国产精品自产拍在线观看55亚洲 | 欧美精品啪啪一区二区三区| 精品人妻熟女毛片av久久网站| 久久精品国产99精品国产亚洲性色 | 在线永久观看黄色视频| 国产区一区二久久| 国产精品久久久久久精品古装| 黄频高清免费视频| 男男h啪啪无遮挡| 国产精品影院久久| 亚洲熟女精品中文字幕| 国产精品免费视频内射| 日本a在线网址| 脱女人内裤的视频| 宅男免费午夜| 国产激情久久老熟女| 久久久久久久国产电影| 18在线观看网站| 女人爽到高潮嗷嗷叫在线视频| 国产日韩欧美亚洲二区| 别揉我奶头~嗯~啊~动态视频| 久久精品亚洲熟妇少妇任你| 啦啦啦 在线观看视频| 大片电影免费在线观看免费| videos熟女内射| 青草久久国产| 在线观看66精品国产| 一个人免费在线观看的高清视频| 精品少妇久久久久久888优播| 国产又爽黄色视频| e午夜精品久久久久久久| 亚洲精品在线美女| 久久精品成人免费网站| 亚洲午夜精品一区,二区,三区| 欧美日本中文国产一区发布| 亚洲精品国产色婷婷电影| 人人妻,人人澡人人爽秒播| 亚洲精华国产精华精| 精品卡一卡二卡四卡免费| 国产主播在线观看一区二区| 操美女的视频在线观看| 悠悠久久av| 亚洲一码二码三码区别大吗| 91九色精品人成在线观看| 91麻豆精品激情在线观看国产 | 亚洲天堂av无毛| 亚洲午夜理论影院| 国产av一区二区精品久久| 99精品久久久久人妻精品| 国产精品免费视频内射| 欧美午夜高清在线| 亚洲第一欧美日韩一区二区三区 | 国产精品 国内视频| 久久精品国产综合久久久| 日本精品一区二区三区蜜桃| 久久久久精品国产欧美久久久| 91成人精品电影| 男人操女人黄网站| 久久国产精品影院| 天天操日日干夜夜撸| 亚洲av片天天在线观看| 在线天堂中文资源库| 一级毛片电影观看| 丁香欧美五月| 国产区一区二久久| 亚洲精品在线观看二区| 视频区图区小说| 曰老女人黄片| 中文字幕人妻丝袜一区二区| 999精品在线视频| 美女午夜性视频免费| 成人免费观看视频高清| 久久久久久亚洲精品国产蜜桃av| 99国产精品一区二区三区| 丝瓜视频免费看黄片| 女性生殖器流出的白浆| 最新在线观看一区二区三区| 在线观看舔阴道视频| 美女午夜性视频免费| 天天操日日干夜夜撸| 少妇的丰满在线观看| 欧美精品啪啪一区二区三区| 欧美变态另类bdsm刘玥| 成年人黄色毛片网站| 啦啦啦在线免费观看视频4| 伊人久久大香线蕉亚洲五| 露出奶头的视频| 操美女的视频在线观看| 精品卡一卡二卡四卡免费| 国产淫语在线视频| 欧美亚洲 丝袜 人妻 在线| 国产精品电影一区二区三区 | 侵犯人妻中文字幕一二三四区| 亚洲视频免费观看视频| 国产精品偷伦视频观看了| 中文字幕最新亚洲高清| 女人被躁到高潮嗷嗷叫费观| 五月开心婷婷网| 菩萨蛮人人尽说江南好唐韦庄| 91精品国产国语对白视频| 亚洲 国产 在线| 亚洲一码二码三码区别大吗| 青青草视频在线视频观看| 极品少妇高潮喷水抽搐| 亚洲国产欧美一区二区综合| 50天的宝宝边吃奶边哭怎么回事| 狠狠精品人妻久久久久久综合| 亚洲精品中文字幕一二三四区 | 丰满饥渴人妻一区二区三| 国产一区二区 视频在线| 极品少妇高潮喷水抽搐| av网站免费在线观看视频| 无人区码免费观看不卡 | 十八禁高潮呻吟视频| 一级,二级,三级黄色视频| 真人做人爱边吃奶动态| 丰满饥渴人妻一区二区三| 午夜福利在线免费观看网站| 天堂8中文在线网| 亚洲精品久久成人aⅴ小说| 如日韩欧美国产精品一区二区三区| 免费久久久久久久精品成人欧美视频| 亚洲精品中文字幕在线视频| 色94色欧美一区二区| 久久这里只有精品19| 丝袜美足系列| 99久久人妻综合| 亚洲av日韩精品久久久久久密| 久久久久视频综合| 亚洲精品在线美女| 91av网站免费观看| 最新美女视频免费是黄的| 日本黄色视频三级网站网址 | 肉色欧美久久久久久久蜜桃| svipshipincom国产片| 美女视频免费永久观看网站| 久久人妻熟女aⅴ| 老司机福利观看| 一边摸一边做爽爽视频免费| 国产在线免费精品| 色综合欧美亚洲国产小说| 久久国产精品影院| 老司机影院毛片| 亚洲精品国产色婷婷电影| 另类精品久久| 欧美激情高清一区二区三区| 黑人猛操日本美女一级片| 乱人伦中国视频| 这个男人来自地球电影免费观看| 丰满少妇做爰视频| 热99久久久久精品小说推荐| 亚洲成国产人片在线观看| 精品国产亚洲在线| 中文字幕另类日韩欧美亚洲嫩草| 久久人妻av系列| 不卡一级毛片| 日韩欧美免费精品| 亚洲精品av麻豆狂野| 天天躁狠狠躁夜夜躁狠狠躁| 18禁黄网站禁片午夜丰满| 亚洲精品中文字幕在线视频| 国产亚洲欧美精品永久| 伊人久久大香线蕉亚洲五| 69精品国产乱码久久久| 纯流量卡能插随身wifi吗| 最黄视频免费看| 中文字幕制服av| 欧美日韩福利视频一区二区| 亚洲五月色婷婷综合| 91av网站免费观看| 国产精品国产高清国产av | 视频区图区小说| 人人妻人人添人人爽欧美一区卜| 国产一区二区三区综合在线观看| 91精品国产国语对白视频| 亚洲成av片中文字幕在线观看| 两个人看的免费小视频| 99re6热这里在线精品视频| 黄色a级毛片大全视频| 亚洲精品美女久久久久99蜜臀| 黄色怎么调成土黄色| 欧美日本中文国产一区发布| 久久ye,这里只有精品| 欧美老熟妇乱子伦牲交| 亚洲欧洲精品一区二区精品久久久| 欧美变态另类bdsm刘玥| 亚洲情色 制服丝袜| a级片在线免费高清观看视频| 久久午夜综合久久蜜桃| 十八禁网站免费在线| 我的亚洲天堂| 欧美日韩中文字幕国产精品一区二区三区 | 一本久久精品| 纵有疾风起免费观看全集完整版| 黄色成人免费大全| 久久精品亚洲av国产电影网| 久久久久久人人人人人| 欧美人与性动交α欧美精品济南到| 在线亚洲精品国产二区图片欧美| 精品国产一区二区久久| 亚洲国产毛片av蜜桃av| 国产精品 欧美亚洲| 国产一卡二卡三卡精品| 99精品在免费线老司机午夜| 日韩视频一区二区在线观看| www日本在线高清视频| 久久99一区二区三区| 国产精品久久久久久精品电影小说| 一级片免费观看大全| 在线观看免费视频日本深夜| 久久免费观看电影| av不卡在线播放| 亚洲欧美一区二区三区黑人| 国产精品1区2区在线观看. | 操美女的视频在线观看| 精品一区二区三卡| 黄色丝袜av网址大全| 美女高潮喷水抽搐中文字幕| 国产1区2区3区精品| 精品人妻熟女毛片av久久网站| 免费一级毛片在线播放高清视频 | 免费日韩欧美在线观看| 亚洲一区二区三区欧美精品| 老司机靠b影院| bbb黄色大片| 亚洲少妇的诱惑av| 2018国产大陆天天弄谢| 91麻豆精品激情在线观看国产 | 久久久久精品国产欧美久久久| 久久久欧美国产精品| 天堂8中文在线网| av有码第一页| 欧美性长视频在线观看| 色精品久久人妻99蜜桃| 飞空精品影院首页| 国产区一区二久久| 久久久精品免费免费高清| 国产日韩一区二区三区精品不卡| 亚洲熟妇熟女久久| 夜夜骑夜夜射夜夜干| cao死你这个sao货| 久久国产精品影院| 欧美日韩福利视频一区二区| 亚洲成人免费av在线播放| 亚洲精品乱久久久久久| 他把我摸到了高潮在线观看 | 欧美激情高清一区二区三区| 亚洲欧美精品综合一区二区三区| 久9热在线精品视频| 99精品久久久久人妻精品| 亚洲一区中文字幕在线| 国产成人影院久久av| 悠悠久久av| 免费不卡黄色视频| 国产主播在线观看一区二区| 久久久国产一区二区| 日韩欧美一区二区三区在线观看 | 国产日韩一区二区三区精品不卡| av有码第一页| 精品少妇久久久久久888优播| 亚洲人成77777在线视频| 欧美国产精品va在线观看不卡| av网站免费在线观看视频| 动漫黄色视频在线观看| 日本撒尿小便嘘嘘汇集6| 男女无遮挡免费网站观看| 久久国产精品人妻蜜桃| 国产一区二区三区在线臀色熟女 | 午夜福利视频精品| 国产成人精品无人区| 成人特级黄色片久久久久久久 | 久热爱精品视频在线9| 免费观看a级毛片全部| 亚洲精品在线观看二区| 久久久久视频综合| 国产伦理片在线播放av一区| 9191精品国产免费久久| 久久中文字幕一级| 曰老女人黄片| 黄片大片在线免费观看| 狠狠精品人妻久久久久久综合| 少妇的丰满在线观看| 亚洲视频免费观看视频| 国产成人精品久久二区二区免费| 人成视频在线观看免费观看| 免费在线观看影片大全网站| av片东京热男人的天堂| 国产精品久久久人人做人人爽| 亚洲精品久久午夜乱码| 老司机影院毛片| 在线 av 中文字幕| 日本av免费视频播放| 12—13女人毛片做爰片一| 国产麻豆69| 国产高清激情床上av| 久久青草综合色| 日韩欧美免费精品| 丰满饥渴人妻一区二区三| 亚洲伊人久久精品综合| 另类亚洲欧美激情| 丝袜美足系列| 一级,二级,三级黄色视频| 狠狠精品人妻久久久久久综合| 大码成人一级视频| 日本精品一区二区三区蜜桃| 高清欧美精品videossex| 18在线观看网站| 久久人人97超碰香蕉20202| 久久久国产一区二区| 亚洲精品美女久久久久99蜜臀| 成人永久免费在线观看视频 | 91字幕亚洲| 亚洲avbb在线观看| 一二三四社区在线视频社区8| 黑人操中国人逼视频| 一级,二级,三级黄色视频| 亚洲专区中文字幕在线| 熟女少妇亚洲综合色aaa.| 精品乱码久久久久久99久播| 国产成+人综合+亚洲专区| 超色免费av| 新久久久久国产一级毛片| 国产人伦9x9x在线观看| 黄色视频,在线免费观看| 又紧又爽又黄一区二区| 别揉我奶头~嗯~啊~动态视频| 巨乳人妻的诱惑在线观看| 精品少妇久久久久久888优播| 天堂中文最新版在线下载| 建设人人有责人人尽责人人享有的| 色婷婷av一区二区三区视频| 黑丝袜美女国产一区| 亚洲午夜精品一区,二区,三区| 欧美人与性动交α欧美精品济南到| 国产成人系列免费观看| 精品一区二区三区av网在线观看 | 日日夜夜操网爽| 久久99一区二区三区| 亚洲国产欧美日韩在线播放| 色综合欧美亚洲国产小说| 国产一区二区三区综合在线观看| 在线 av 中文字幕| av福利片在线| 久热这里只有精品99| 亚洲中文日韩欧美视频| 1024视频免费在线观看| 亚洲精品在线观看二区| 最新美女视频免费是黄的| 精品国产乱码久久久久久男人| 成人特级黄色片久久久久久久 | 亚洲 国产 在线| 多毛熟女@视频| 露出奶头的视频| 日韩一区二区三区影片| 国产单亲对白刺激| 国产欧美日韩精品亚洲av| 超碰成人久久| 最黄视频免费看| 日韩欧美一区视频在线观看| 丰满人妻熟妇乱又伦精品不卡| 亚洲人成77777在线视频| 麻豆乱淫一区二区| 18禁裸乳无遮挡动漫免费视频| 99re6热这里在线精品视频| 色婷婷久久久亚洲欧美| 免费在线观看黄色视频的| 日韩欧美一区视频在线观看| 色综合婷婷激情| 18在线观看网站| 丝袜喷水一区| 黄色怎么调成土黄色| 欧美在线一区亚洲| 丝瓜视频免费看黄片| 久久午夜综合久久蜜桃| 免费观看av网站的网址| 国产高清视频在线播放一区| 色尼玛亚洲综合影院| 露出奶头的视频| 天堂俺去俺来也www色官网| 老司机午夜福利在线观看视频 | 久久午夜综合久久蜜桃| 免费女性裸体啪啪无遮挡网站| 麻豆成人av在线观看| 久久久精品国产亚洲av高清涩受| 欧美激情 高清一区二区三区| 成人永久免费在线观看视频 | 搡老岳熟女国产| 国产1区2区3区精品| 99riav亚洲国产免费| 波多野结衣av一区二区av| 国产精品电影一区二区三区 | 搡老乐熟女国产| 中文字幕人妻丝袜制服| 亚洲国产成人一精品久久久| www.精华液| 亚洲九九香蕉| 国产高清视频在线播放一区| 国产片内射在线| 肉色欧美久久久久久久蜜桃| 在线亚洲精品国产二区图片欧美| 亚洲欧洲精品一区二区精品久久久| 肉色欧美久久久久久久蜜桃| 老汉色∧v一级毛片| svipshipincom国产片| 久久人妻福利社区极品人妻图片| 成人av一区二区三区在线看| 免费av中文字幕在线| 俄罗斯特黄特色一大片| 飞空精品影院首页| 国产高清videossex| 黄频高清免费视频| 丝袜在线中文字幕| www.熟女人妻精品国产| 天堂中文最新版在线下载| 亚洲 国产 在线| 91老司机精品|